Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma
Cristina Pérez(Universidad de Murcia), Bruno Paiva(Navarre Institute of Health Research), Laura Rosiñol(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Felipe Prósper(Institute of Human Genetics), Cirino Botta(Ospedale Annunziata di Cosenza), Juan José Lahuerta(Research Institute Hospital 12 de Octubre), Jesús F. San Miguel(Clinica Universidad de Navarra), Catarina Maia(Navarre Institute of Health Research), María‐Victoria Mateos(Hospital Clínico San Carlos), Diego Alignani(Navarre Institute of Health Research), Joan Bladé(Hospital Clínic de Barcelona), Javier de la Rubia(Universitat de València), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Joan Bargay(Hospital Son Llatzer), María‐Teresa Cedena(Hospital Universitario 12 De Octubre), Noemí Puig(Instituto de Investigación Biomédica de Salamanca), Edurne San José‐Eneriz(Navarre Institute of Health Research), Xabier Agirre(Universidad de Navarra), Albert Oriol(Institut Català d'Oncologia), Ibai Goicoechea(Navarre Institute of Health Research), Marco Rossi(Magna Graecia University), Caterina Riillo(Magna Graecia University), Rafael Martínez(Hospital Clínico San Carlos), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Patricia Maiso(Weatherford College), Paula Rodríguez‐Otero(Clinica Universidad de Navarra), Daniel Alameda(Navarre Institute of Health Research), Amaia Vilas‐Zornoza(Clinica Universidad de Navarra), Alberto Órfão(Universidad de Salamanca), David Lara‐Astiaso(Wellcome/MRC Cambridge Stem Cell Institute), Aintzane Zabaleta(Navarre Institute of Health Research), Jesús Martín(Instituto de Biomedicina de Sevilla), Rafael Ríos(Hospital Universitario 12 De Octubre), Juana Merino(Navarre Institute of Health Research), Irene Manrique(Navarre Institute of Health Research), María‐Jesús Blanchard(Hospital Universitario Ramón y Cajal), Sarai Sarvide(Navarre Institute of Health Research)
Cited by 156
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
|Cell|2020|2.3k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k